Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Journal of Visualized Experiments · 2023
DOI: 10.3791/64558 ↗Kurz gefasst
Video/Audio in der Zeitschrift Journal of Visualized Experiments, 2023. Verfasst von Tommaso Sconocchia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Internal Medicine, Medical University of Graz. Hauptthemen laut MEDLINE: Gain of Function Mutation, Gene Editing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Austrian Science Fund FWF.
Abstract (Originalsprache)
Throughout their lifetime, hematopoietic stem and progenitor cells (HSPCs) acquire somatic mutations. Some of these mutations alter HSPC functional properties such as proliferation and differentiation, thereby promoting the development of hematologic malignancies. Efficient and precise genetic manipulation of HSPCs is required to model, characterize, and better understand the functional consequences of recurrent somatic mutations. Mutations can have a deleterious effect on a gene and result in loss-of-function (LOF) or, in stark contrast, may enhance function or even lead to novel characteristics of a particular gene, termed gain-of-function (GOF). In contrast to LOF mutations, GOF mutations almost exclusively occur in a heterozygous fashion. Current genome-editing protocols do not allow for the selective targeting of individual alleles, hampering the ability to model heterozygous GOF mutations. Here, we provide a detailed protocol on how to engineer heterozygous GOF hotspot mutations in human HSPCs by combining CRISPR/Cas9-mediated homology-directed repair and recombinant AAV6 technology for efficient DNA donor template transfer. Importantly, this strategy makes use of a dual fluorescent reporter system to allow for the tracking and purification of successfully heterozygously edited HSPCs. This strategy can be employed to precisely investigate how GOF mutations affect HSPC function and their progression toward hematological malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Hematology, Department of Internal Medicine, Medical University of Graz.
- Division of Hematology, Stanford Cancer Institute, Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine.
- Division of Hematology, Department of Internal Medicine, Medical University of Graz; Department of Blood Group Serology and Transfusion Medicine, Medical University of Graz; a.reinisch@medunigraz.at.
Förderung
- Austrian Science Fund FWF
Zitieren
APA
Sconocchia, T., Foßelteder, J., Köhnke, T., Majeti, R., & Reinisch, A. (2023). Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells. Journal of Visualized Experiments. https://doi.org/10.3791/64558
Vancouver
Sconocchia T, Foßelteder J, Köhnke T, Majeti R, Reinisch A. Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells. Journal of Visualized Experiments. 2023. doi:10.3791/64558
BibTeX
@article{Sconocchia2023,
author = {Sconocchia, Tommaso and Foßelteder, Johannes and Köhnke, Thomas and Majeti, Ravindra and Reinisch, Andreas},
title = {Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells},
journal = {Journal of Visualized Experiments},
year = {2023},
doi = {10.3791/64558}
}
EUVIMED